Geoffrey Beran Rose - Mar 1, 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Commercial Officer
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Geoffrey Beran Rose
Stock symbol
LUNG
Transactions as of
Mar 1, 2022
Transactions value $
-$11,038
Form type
4
Date filed
3/3/2022, 05:13 PM
Previous filing
Dec 16, 2021
Next filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$11K -426 -0.34% $25.91 124K Mar 1, 2022 Direct F1, F2
transaction LUNG Common Stock Award $0 +31K +25.06% $0.00 155K Mar 1, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +68.7K $0.00 68.7K Mar 1, 2022 Common Stock 68.7K $26.56 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 Includes 669 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2022.
F3 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.
F4 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.